Connect With Us:
HEAR. HELP. HEAL. HOPE.
The ADAP Advocacy Association (aaa+®) mission is to promote and enhance the AIDS Drug Assistance Programs (ADAPs) and improve access to care for persons living with HIV/AIDS. aaa+® works with advocates, community, health care, government, patients, pharmaceutical companies and other stakeholders to raise awareness, offer patient educational programs, and foster greater community collaboration.
aaa+® is the only national grassroots organization focused exclusively on ADAP and ensuring that there are adequate resources nationwide to eliminate or prevent waiting lists for services. Our purpose is to better engage people living with HIV/AIDS by providing a platform whereby they can offer their personal experiences, challenges, knowledge, insight and solutions to solving this perpetual problem.
The ADAP Blog focuses on the the federal commitment to fully fund the AIDS Drug Assistance Program (ADAP) for people living with HIV/AIDS.
Go to: Giving Thanks
The ADAP Directory is a convenient online resource to locate information about the AIDS Drugs Assistance Program for all U.S. states and territories.
The ADAP Watch monitors ADAP Waiting Lists, as reported by the National Alliance of State & Territorial AIDS Directors (NASTAD).
Go to: National ADAP Monitoring Project - 2021-2022 Annual Report
SYNC 2022 will be held as a virtual conference on December 6-8, 2022 with a diverse range of thousands of participants including medical providers, healthcare workers, state, local and federal government officials, faith and community-based organizations, and others addressing the many disciplines within SYNC. Register today!
The ADAP Scholarship Fund is a restricted fund to provide scholarships for people living with HIV/AIDS and their supporters so they can attend ADAP-related advocacy and educational events.
In 2022, we've raised $8,940.00 toward our goal of $15,000.00. Please help to support these advocates by donating online today.
ADAP Advocacy Association Launches Member365 ADAP Community.
ANNUAL REPORT
Read our: 2021 Annual Report.